title: 7,12-Dimethylbenz[a]anthracene exposure induces the DNA repair response in neonatal rat ovaries.
abstract: 7,12-Dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles at all stages of development. This study investigated DMBA-induced DNA double strand break (DSB) formation with subsequent activation of the ovarian DNA repair response in models of pre-antral or pre-ovulatory follicle loss. Postnatal day (PND) 4 Fisher 344 (F344) rat ovaries were cultured for 4 days followed by single exposures of vehicle control (1% DMSO) or DMBA (12.5 nM or 75 nM) and maintained in culture for 4 or 8 days. Alternately, PND4 F344 rat ovaries were exposed to 1 μM DMBA at the start of culture for 2 days. Total RNA or protein was isolated, followed by qPCR or Western blotting to quantify mRNA or protein level, respectively. γH2AX and phosphorylated ATM were localized and quantified using immunofluorescence staining. DMBA exposure increased caspase 3 and γH2AX protein. Additionally, DMBA (12.5 nM and 1 μM) increased levels of mRNA encoding Atm, Xrcc6, Brca1 and Rad51. In contrast, Parp1 mRNA was decreased on d4 and increased on d8 of DMBA exposure, while PARP1 protein increased after 8 days of DMBA exposure. Total ATM increased in a concentration-dependent temporal pattern (75 nM d4; 12.5 nM d8), while pATM was localized in large primary and secondary follicles and increased after 8 days of 75 nM DMBA exposure compared to both control and 12.5 nM DMBA. These findings support that, despite some concentration effects, DMBA induces ovarian DNA damage and that DNA repair mechanisms are induced as a potential mechanism to prevent follicle loss.
authors: Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: shanthig@iastate.edu.
authors: Shanthi
authors: S
authors: Ganesan
authors: Poulomi
authors: P
authors: Bhattacharya
authors: Aileen F
authors: AF
authors: Keating
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity*; D000818:Animals; D000831:Animals, Newborn; D002273:Carcinogens / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D004260:DNA Repair / Q000187:drug effects* / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D002273:Carcinogens; D015127:9,10-Dimethyl-1,2-benzanthracene
keywords: 7,12-Dimethylbenz[a]anthracene; DNA damage; DNA double strand break repair; Ovotoxicity
references: Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
references: 10959836
references: Sci Transl Med. 2013 Feb 13;5(172):172ra21
references: 23408054
references: Toxicol Sci. 2007 Apr;96(2):327-34
references: 17204581
references: Mutat Res. 2010 Mar 1;685(1-2):54-60
references: 19682466
references: Trends Endocrinol Metab. 2007 Mar;18(2):58-65
references: 17275321
references: Carcinogenesis. 2003 Oct;24(10):1571-80
references: 12919958
references: Toxicol Appl Pharmacol. 2005 Mar 1;203(2):114-23
references: 15710172
references: Maturitas. 2000 Apr 28;35(1):3-9
references: 10802394
references: Biochem J. 1999 Sep 1;342 ( Pt 2):249-68
references: 10455009
references: Biochem Pharmacol. 2012 Jul 15;84(2):137-46
references: 22469522
references: Int J Proteomics. 2011;2011:373816
references: 22084686
references: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13978-82
references: 10570184
references: Cell. 1997 Jan 24;88(2):265-75
references: 9008167
references: Toxicol Appl Pharmacol. 2002 Oct 15;184(2):107-15
references: 12408955
references: Science. 2002 Jul 12;297(5579):259-63
references: 12114629
references: Mutagenesis. 1991 Mar;6(2):113-6
references: 1905382
references: Hum Reprod. 2008 Mar;23(3):699-708
references: 18192670
references: Annu Rev Pharmacol Toxicol. 2001;41:367-401
references: 11264462
references: Autophagy. 2009 Jan;5(1):61-74
references: 19001878
references: Mol Pharmacol. 2008 Jan;73(1):137-46
references: 17925458
references: FEBS Lett. 2006 Jul 10;580(16):3995-9
references: 16806193
references: J Mol Biol. 2003 Feb 7;326(1):93-103
references: 12547193
references: Endocr Rev. 2000 Apr;21(2):200-14
references: 10782364
references: Toxicol Appl Pharmacol. 2000 Sep 15;167(3):191-8
references: 10986010
references: Nat Rev Cancer. 2008 Mar;8(3):193-204
references: 18256616
references: Nat Rev Cancer. 2003 Mar;3(3):155-68
references: 12612651
references: Development. 1998 Oct;125(20):4007-17
references: 9735362
references: Toxicol Appl Pharmacol. 2011 Jun 1;253(2):94-102
references: 21439308
references: Nucleic Acids Res. 2001 May 1;29(9):e45
references: 11328886
references: DNA Repair (Amst). 2010 Dec 10;9(12):1307-14
references: 21030321
references: Toxicol Appl Pharmacol. 2014 May 1;276(3):179-87
references: 24576726
references: Int Rev Cytol. 1991;124:43-101
references: 2001918
references: Methods Enzymol. 2006;409:493-510
references: 16793420
references: Physiol Rev. 1980 Oct;60(4):1107-66
references: 7001511
references: Toxicol Appl Pharmacol. 2009 Feb 1;234(3):361-9
references: 19027032
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Bioessays. 2001 Jun;23(6):543-8
references: 11385634
references: Genes Dev. 1997 Sep 15;11(18):2347-58
references: 9308963
references: Annu Rev Pharmacol Toxicol. 1996;36:307-31
references: 8725392
references: J Mol Biol. 2012 Mar 30;417(3):197-211
references: 22306462
references: Nat Rev Genet. 2001 Mar;2(3):196-206
references: 11256071
references: J Clin Invest. 2007 Dec;117(12):3971-8
references: 18037991
references: West J Med. 1979 Mar;130(3):235
references: 18748389
references: Gynecol Oncol. 2009 Mar;112(3):610-5
references: 19150572
references: Environ Health Perspect. 1983 Feb;48:43-52
references: 6825634
references: Cell Cycle. 2007 Apr 15;6(8):931-42
references: 17457059
references: Biol Reprod. 2007 Sep;77(3):442-51
references: 17554082
references: J Cell Biol. 2010 Jul 26;190(2):197-207
references: 20660628